Skip to content

Combined triglyceride-glucose index and systemic inflammation for long-term risk stratification in major adverse cardiovascular events: a 10-year prospective study.

Aug 2026 · Coronary Artery Disease · 0 citations · 32 references
Medicine

TL;DR

Integrating systemic inflammation, particularly SIRI, with the TyG index significantly enhances long-term cardiovascular risk reclassification in CAD patients, and this simple and cost-effective approach based on routine laboratory parameters may improve risk stratification and support more targeted secondary prevention.

Abstract

Background

AND

Aims

Insulin resistance and systemic inflammation are key drivers of atherosclerosis but are typically evaluated separately. This study aimed to determine whether integrating the triglyceride-glucose (TyG) index with inflammatory markers improves long-term risk stratification for major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD).

Methods

AND

Results

In this prospective cohort study, 9316 CAD patients were followed for 10 years. Cox regression models were used to assess associations between the TyG index and inflammatory markers with MACE. Incremental predictive value was evaluated using net reclassification improvement (NRI) and integrated discrimination improvement. The combined TyG-inflammation models were significantly associated with an increased risk of 10-year MACE, corresponding to a 19.1% relative increase in hazard. Among the evaluated models, the TyG + systemic inflammation response index (SIRI) combination demonstrated the most consistent performance, primarily through improving risk reclassification rather than discrimination. The model achieved an NRI of 5.5% for overall MACE and 15.4% for cardiac death, indicating improved identification of high-risk patients who would not be detected by the TyG index alone.

Conclusion

Integrating systemic inflammation, particularly SIRI, with the TyG index significantly enhances long-term cardiovascular risk reclassification in CAD patients. This simple and cost-effective approach based on routine laboratory parameters may improve risk stratification and support more targeted secondary prevention.

View source

Similar papers

Open access Sep 2026

Comparative associations of cumulative cholesterol-HDL-glucose index and triglyceride-glucose index with risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study

Investigating the impact of cumulative CHG index on CVD development in individuals with CKM syndrome stages 0–3 and compared the predictive performances of triglyceride-glucose (TyG) index and CHG index for CVD suggests that longitudinal monitoring of CHG index and TyG index may provide additional information for CVD r...

Jiabaili Wang, Qian Liu, Meng-Hui Li et al. · 0 citations
Open access Oct 2026

The Triglyceride-Glucose Index Stratifies Cardiovascular Risk After PCI: A Cohort Study Identifying the Highest-Risk Patients.

BACKGROUND The triglyceride-glucose (TyG) index is a surrogate marker of insulin resistance, but its prognostic value across guideline-defined cardiovascular risk strata remains unclear. METHODS In this retrospective cohort study, 23,592 patients undergoing percutaneous coronary intervention (PCI) were stratified int...

Bo-Wen Li, Zhi-Hao Zheng, Ji-Ning He et al. · 0 citations
Open access Oct 2026

A novel metabolic imbalance index combining insulin resistance and inflammation for cardiovascular prognosis: evidence from three international cohorts in middle-aged and older adults

A metabolic–inflammatory index based on the estimated glucose disposal rate (eGDR) to capture the combined contribution of these pathways to long-term CVD risk is developed, highlighting metabolic impairment as a key factor through which inflammation drives cardiovascular risk.

M.-L. Liu, K. Yan, K.-X. Zhang et al. · 0 citations
Open access Sep 2026

Predictive value of baseline, cumulative exposure and annual mean changes in TyG-related indices for cardiovascular events in older rural adults with cardiovascular-kidney-metabolic syndrome stages 0–3: a cohort study

Baseline and cumulative TyG-WC demonstrated relatively better predictive performance and, especially baseline measure, may serve as a simple and low-cost auxiliary tool for cardiovascular risk stratification in resource-constrained primary care settings, though it should not replace conventional cardiovascular risk-ass...

Yan Xue, Qing-Xiu Tian, Rong Zhang et al. · 0 citations
Open access Oct 2026

Low-grade chronic inflammation is associated with cardiovascular risk factors but does not improve atherosclerosis stratification by the SCORE2 risk score

Low-grade chronic inflammation is increasingly recognized as a key contributor to cardiovascular disease, yet its incremental value in risk stratification beyond established clinical scores remains uncertain. To evaluate the association between inflammatory biomarkers and cardiovascular risk factors, and t...

A. d'Aiello, F. Jiménez-Trinidad, A. Severino et al. · 0 citations
#protein folding Open access Oct 2026

Association of Insulin Resistance, Systemic Inflammation, and Atherogenic Dyslipidemia With Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Prospective Cohort Study

Background: Cardiovascular disease remains a major cause of morbidity and mortality in type 2 diabetes mellitus (T2DM), with residual risk persisting despite conventional risk-factor control. Insulin resistance, systemic inflammation, and atherogenic dyslipidemia may jointly contribute to this excess risk. Objective: T...

Nasar Iqbal Ranjha, Faiqa Nasar, Madiha Shah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.